Kerman Aloria

Dr. Kerman Aloria

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in EMBO Reports
Verified
Journal Article
Open access
PDF file
KAKerman Aloria
Kerman Aloria
BSBrenda Schilke
Brenda Schilke
AAAmy Andrew
Amy Andrew
ECElizabeth A. Craig
Elizabeth A. Craig
The neurodegenerative disease Friedreich's ataxia is caused by reduced levels of frataxin, a mitochondrial matrix protein. The in vivo role of frataxin is under debate. Frataxin, as well as its yeast homologue Yfh1, binds multiple iron atoms as an oligomer and has been proposed to function as a crucial iron‐storage protein. We identified a mutant Yfh1 defective in iron‐induced oligomerization. This mutant protein was able to replace functionally wild‐type Yfh1, even when expressed at low levels, when mitochondrial iron levels were high and in mutant strains having deletions of genes that had synthetic growth defects with a YFH1 deletion. The ability of an oligomerization‐deficient Yfh1 to function in vivo suggests that oligomerization, and thus oligomerization‐induced iron storage, is not a critical function of Yfh1. Rather, the capacity of this oligomerization‐deficient mutant to interact with the Isu protein suggests a more direct role of Yfh1 in iron–sulphur cluster biogenesis.

24 June 2011 in Eye
Verified
Journal Article
Closed access
AAA Acera
A Acera
Elena VecinoElena Vecino
Elena Vecino
IRI Rodríguez-Agirretxe
I Rodríguez-Agirretxe
KAKerman Aloria
Kerman Aloria
JAJesus M. Arizmendi
Jesus M. Arizmendi
JCJuan Durán de la Colina
Juan Durán de la Colina

1 January 2014 in Journal of Proteomics
Verified
Journal Article
Open access
RGRaquel González-Fernández
Raquel González-Fernández
KAKerman Aloria
Kerman Aloria
JVJose Valero
Jose Valero
IRInmaculada Redondo
Inmaculada Redondo
JAJesus M. Arizmendi
Jesus M. Arizmendi
JJJesus V Jorrin-Novo
Jesus V Jorrin-Novo
The necrotrophic fungus Botrytis cinerea is a very damaging phytopathogen of wide host range and environmental persistence. It is difficult to control because of its genetic versatility, expressed in the many phenotypical differences among isolates. The genomes of the B. cinerea B05.10 and T4 strains have been recently sequenced, becoming a model system for necrotrophic pathogens, and thus opening new alternatives for functional genomics analysis. In this work, the mycelium and secreted proteome of six wild-type strains with different host range, and grown in liquid minimal medium, have been analyzed by using complementary gel-based (1-DE and 2-DE) and gel-free/label-free (nUPLC-MS(E)) approaches. We found differences in the protein profiles among strains belonging to both the mycelium and the secretome. A total of 47 and 51 variable proteins were identified in the mycelium and the secretome, respectively. Some of them, such as malate dehydrogenase or peptidyl-prolyl cis-trans isomerase from the mycelium, and endopolygalacturonase, aspartic protease or cerato-platanin protein from the secretome have been reported as virulence factors, which are involved in host-tissue invasion, pathogenicity or fungal development. The necrotrophic fungus Botrytis cinerea is an important phytopathogen of wide host range and environmental persistence, causing substantial economic losses worldwide. In this work, the mycelium and secreted proteome of six B. cinerea wild-type strains with different host range have been analyzed by using complementary gel-based and gel-free/label-free approaches. Fungal genetic versatility was confirmed at the proteome level for both mycelium proteome and secreted proteins. A high number of hypothetical proteins with conserved domains related to toxin compounds or to unknown functions were identified, having qualitative differences among strains. The identification of hypothetical proteins suggests that the B. cinerea strains differ mostly in processes involved in adaptation to a particular environment or a growth condition, rather than in essential metabolic reactions. Proteomics can help in the identification of variable proteins related to the infection and colonization of host plant tissues, as well as of virulence and aggressiveness factors among different B. cinerea wild-type strains. This article is part of a Special Issue entitled: Trends in Microbial Proteomics.

13 March 2000 in FEBS Letters
Verified
Journal Article
Closed access
LMLara Martı́n
Lara Martı́n
MFMónica L Fanarraga
Mónica L Fanarraga
KAKerman Aloria
Kerman Aloria
JZJuan C Zabala
Juan C Zabala

1 December 2013 in Journal of Proteomics
Verified
Journal Article
Closed access
SMSalvador Martínez-Bartolomé
Salvador Martínez-Bartolomé
EDEric W. Deutsch
Eric W. Deutsch
PBPierre-Alain Binz
Pierre-Alain Binz
AJAndrew R. Jones
Andrew R. Jones
MEMartin Eisenacher
Martin Eisenacher
JAJuan P. Albar
Juan P. Albar

1 June 2016 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
NONerea Osinalde
Nerea Osinalde
JMJone Mitxelena
Jone Mitxelena
VSVirginia Sánchez-Quiles
Virginia Sánchez-Quiles
VAVyacheslav Akimov
Vyacheslav Akimov
KAKerman Aloria
Kerman Aloria
IKIrina Kratchmarova
Irina Kratchmarova
Anti-cancer immunotherapies commonly rely on the use of interleukin-2 (IL-2) to promote the expansion of T lymphocytes. IL-2- dependent proliferation is the culmination of a complex network of phosphorylation-driven signaling events that impact on gene transcription through mechanisms that are not clearly understood. To study the role of IL-2 in the regulation of nuclear protein function we have performed an unbiased mass spectrometry-based study of the nuclear phosphoproteome of resting and IL-2-treated CD4+ T lymphocytes. We detected 8521distinct phosphosites including many that are not yet reported in curated phosphorylation databases. Although most phosphorylation sites remained unaffected upon IL-2 treatment, 391 sites corresponding to 288 gene products showed robust IL-2-dependent regulation. Importantly, we show that ATP-citrate lyase (ACLY) is a key phosphoprotein effector of IL-2-mediated T-cell responses. ACLY becomes phosphorylated on serine 455 in T lymphocytes upon IL-2-driven activation of AKT, and depletion or inactivation of ACLY compromises IL-2-promoted T-cell growth. Mechanistically, we demonstrate that ACLY is required for enhancing histone acetylation levels and inducing the expression of cell cycle regulating genes in response to IL-2. Thus, the metabolic enzyme ACLY emerges as a bridge between cytokine signaling and proliferation of T lymphocytes, and may be an attractive candidate target for the development of more efficient anti-cancer immunotherapies.